PCVX Annual Operating Expenses
$388.28 M
+$180.95 M+87.27%
31 December 2023
Summary:
As of January 22, 2025, PCVX annual total operating expenses is $388.28 million, with the most recent change of +$180.95 million (+87.27%) on December 31, 2023. During the last 3 years, it has risen by +$301.17 million (+345.77%). PCVX annual operating expenses is now at all-time high.PCVX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PCVX Quarterly Operating Expenses
$139.63 M
-$12.96 M-8.49%
30 September 2024
Summary:
As of January 22, 2025, PCVX quarterly total operating expenses is $139.63 million, with the most recent change of -$12.96 million (-8.49%) on September 30, 2024. Over the past year, it has increased by +$28.25 million (+25.36%). PCVX quarterly operating expenses is now -8.49% below its all-time high of $152.59 million, reached on June 30, 2024.PCVX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PCVX Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +87.3% | +25.4% |
| 3 y3 years | +345.8% | +423.9% |
| 5 y5 years | +992.7% | +1055.3% |
PCVX Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +280.4% | -8.5% | +382.5% |
| 5 y | 5-year | at high | +620.1% | -8.5% | +791.9% |
| alltime | all time | at high | +992.7% | -8.5% | +1055.3% |
Vaxcyte Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $139.63 M(-8.5%) |
| June 2024 | - | $152.59 M(+33.4%) |
| Mar 2024 | - | $114.35 M(-6.0%) |
| Dec 2023 | $388.28 M(+87.3%) | $121.67 M(+9.2%) |
| Sept 2023 | - | $111.39 M(+31.5%) |
| June 2023 | - | $84.68 M(+20.1%) |
| Mar 2023 | - | $70.54 M(+12.6%) |
| Dec 2022 | $207.33 M(+103.1%) | $62.65 M(+7.2%) |
| Sept 2022 | - | $58.42 M(+23.8%) |
| June 2022 | - | $47.20 M(+20.8%) |
| Mar 2022 | - | $39.06 M(+35.0%) |
| Dec 2021 | $102.08 M | $28.94 M(+8.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $26.65 M(+14.1%) |
| June 2021 | - | $23.35 M(+0.9%) |
| Mar 2021 | - | $23.14 M(+21.0%) |
| Dec 2020 | $87.10 M(+61.6%) | $19.13 M(-6.8%) |
| Sept 2020 | - | $20.52 M(+1.6%) |
| June 2020 | - | $20.19 M(-26.0%) |
| Mar 2020 | - | $27.27 M(+74.2%) |
| Dec 2019 | $53.92 M(+51.7%) | $15.66 M(+29.5%) |
| Sept 2019 | - | $12.09 M(-1.2%) |
| June 2019 | - | $12.23 M(-12.3%) |
| Mar 2019 | - | $13.94 M |
| Dec 2018 | $35.53 M | - |
FAQ
- What is Vaxcyte annual total operating expenses?
- What is the all time high annual operating expenses for Vaxcyte?
- What is Vaxcyte annual operating expenses year-on-year change?
- What is Vaxcyte quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Vaxcyte?
- What is Vaxcyte quarterly operating expenses year-on-year change?
What is Vaxcyte annual total operating expenses?
The current annual operating expenses of PCVX is $388.28 M
What is the all time high annual operating expenses for Vaxcyte?
Vaxcyte all-time high annual total operating expenses is $388.28 M
What is Vaxcyte annual operating expenses year-on-year change?
Over the past year, PCVX annual total operating expenses has changed by +$180.95 M (+87.27%)
What is Vaxcyte quarterly total operating expenses?
The current quarterly operating expenses of PCVX is $139.63 M
What is the all time high quarterly operating expenses for Vaxcyte?
Vaxcyte all-time high quarterly total operating expenses is $152.59 M
What is Vaxcyte quarterly operating expenses year-on-year change?
Over the past year, PCVX quarterly total operating expenses has changed by +$28.25 M (+25.36%)